相关实验视频

Updated: Jul 18, 2025

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

放射性药物作为免疫检查点抑制剂的组合伙伴

Jean-Pierre Pouget¹, Timothy A Chan², Lorenzo Galluzzi³

¹Institut de Recherche en Cancérologie de Montpellier (IRCM), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 1194, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.

Trends in cancer

|August 23, 2023

概括

向放射性核素疗法 (TRT) 在与免疫检查点抑制剂 (ICI) 结合时,有望增强癌症治疗. 这种组合可能会改善患者对免疫治疗的反应率,扩大治疗选择.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
放射性药物疗法是一种放射性药物疗法.

背景情况:

免疫检查点抑制剂 (ICI) 已经改变了癌症护理,但只对一小部分患者有益.
开发有效的组合疗法对于扩大ICI疗效至关重要.
向放射性核素疗法 (TRT) 提供潜在的免疫刺激作用和有利的安全性.

研究的目的:

探索有针对性的放射性核素治疗 (TRT) 作为免疫检查点抑制剂 (ICI) 的组合合作伙伴的潜力.
审查支持TRT/ICI组合的临床前和临床证据.

主要方法:

审查研究TRT和ICI组合的临床前癌症模型.
对TRT和ICI疗效和安全的临床研究结果的分析.

主要成果:

在临床前情况下,TRT表现出免疫刺激作用.
TRT显示出良好的安全性和有效性概况.
临床前和临床数据表明,TRT是ICI组合的可行合作伙伴.

结论:

向放射性核素疗法 (TRT) 是一种与免疫检查点抑制剂 (ICI) 结合的有希望的策略.
TRT/ICI组合提供了一个潜在的平台,以提高癌症治疗和患者的治疗结果.

关键词:

外部光束辐射治疗.免疫检查点抑制剂免疫检查点抑制剂免疫性细胞死亡免疫性细胞死亡这是一种炎症炎症炎症炎症.这就是尼沃卢马布 (nivolumab).这就是Pembrolizumab.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...